Bollar Gretchen E, Keith Johnathan D, Stanford Denise D, Oden Ashley M, Raju S Vamsee, Poore T Spencer, Birket Susan E
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama.
Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama.
Am J Pathol. 2025 Feb;195(2):174-187. doi: 10.1016/j.ajpath.2024.09.008. Epub 2024 Oct 28.
Cystic fibrosis (CF) respiratory outcomes are heavily influenced by complications of infection. Pseudomonas aeruginosa and Staphylococcus aureus are the most common colonizers of the cystic fibrosis lung, and frequently overlap to cause chronic and persistent coinfections associated with severe disease. However, the dynamics of P. aeruginosa and S. aureus coinfection and its impacts on the development of CF lung structural damage are poorly understood. Additionally, small colony variants (SCVs) of S. aureus have been associated with P. aeruginosa infections in people with CF, but their role in disease progression is largely unknown. In this work, the CF rat was used to model chronic lung coinfection with P. aeruginosa and S. aureus, using clinically and laboratory-derived normal colony and SCV strains of S. aureus to evaluate the impact of phenotype on clinical outcomes. Rats coinfected with clinically derived S. aureus of both phenotypes experienced increased inflammation in the lung. However, only the combination of P. aeruginosa and clinically normal colony S. aureus led to lung structural decline, including mucus obstruction and bronchiectasis. Regression analyses showed that the damage was associated with a higher burden of P. aeruginosa. These data indicate that chronic coinfection with normal colony S. aureus and P. aeruginosa may support the progression CF lung decline driven by P. aeruginosa, which might be avoided when coinfecting S. aureus exhibits the SCV phenotype.
囊性纤维化(CF)的呼吸道预后受到感染并发症的严重影响。铜绿假单胞菌和金黄色葡萄球菌是囊性纤维化肺部最常见的定植菌,且常同时存在,导致与严重疾病相关的慢性持续性混合感染。然而,铜绿假单胞菌和金黄色葡萄球菌混合感染的动态变化及其对CF肺部结构损伤发展的影响尚不清楚。此外,金黄色葡萄球菌的小菌落变体(SCV)与CF患者的铜绿假单胞菌感染有关,但其在疾病进展中的作用 largely unknown。在这项研究中,使用CF大鼠对铜绿假单胞菌和金黄色葡萄球菌的慢性肺部混合感染进行建模,使用临床和实验室来源的金黄色葡萄球菌正常菌落和SCV菌株来评估表型对临床结果的影响。两种表型的临床来源金黄色葡萄球菌混合感染的大鼠肺部炎症增加。然而,只有铜绿假单胞菌与临床正常菌落金黄色葡萄球菌的组合导致肺部结构衰退,包括黏液阻塞和支气管扩张。回归分析表明,这种损伤与铜绿假单胞菌的较高负荷有关。这些数据表明,正常菌落金黄色葡萄球菌和铜绿假单胞菌的慢性混合感染可能会促进由铜绿假单胞菌驱动的CF肺部衰退进展,而当混合感染的金黄色葡萄球菌表现出SCV表型时,这种情况可能会避免。